US7794704B2
(en)
|
2004-01-23 |
2010-09-14 |
Advanced Cell Technology, Inc. |
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
|
JP2007522131A
(ja)
|
2004-01-23 |
2007-08-09 |
アドバンスド セル テクノロジー、インコーポレイテッド |
網膜変性疾患治療のための改良された様式
|
US8476070B2
(en)
|
2005-08-29 |
2013-07-02 |
Technion Research & Development Foundation Limited |
Media for culturing stem cells
|
US8278104B2
(en)
*
|
2005-12-13 |
2012-10-02 |
Kyoto University |
Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
|
US20090227032A1
(en)
*
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
US8129187B2
(en)
*
|
2005-12-13 |
2012-03-06 |
Kyoto University |
Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
|
AU2006325975B2
(en)
|
2005-12-13 |
2011-12-08 |
Kyoto University |
Nuclear reprogramming factor
|
EP2377925A1
(en)
|
2006-04-14 |
2011-10-19 |
Advanced Cell Technology, Inc. |
Hemangio-colony forming cells
|
DK3441459T3
(da)
|
2006-08-02 |
2021-06-07 |
Technion Res & Dev Foundation |
Fremgangsmåder til ekspansion af embryonale stamceller i en suspensionskultur
|
KR101516833B1
(ko)
|
2007-03-23 |
2015-05-07 |
위스콘신 얼럼나이 리서어치 화운데이션 |
체세포 재프로그래밍
|
US9029147B2
(en)
|
2007-06-15 |
2015-05-12 |
Massachusetts Institute Of Technology |
Methods and compositions for enhanced differentiation from embryonic stem cells
|
US9213999B2
(en)
|
2007-06-15 |
2015-12-15 |
Kyoto University |
Providing iPSCs to a customer
|
JP2008307007A
(ja)
*
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
WO2009051671A1
(en)
|
2007-10-12 |
2009-04-23 |
Advanced Cell Technology, Inc. |
Improved methods of producing rpe cells and compositions of rpe cells
|
AU2008286249B2
(en)
*
|
2007-12-10 |
2013-10-10 |
Kyoto University |
Efficient method for nuclear reprogramming
|
US9683232B2
(en)
|
2007-12-10 |
2017-06-20 |
Kyoto University |
Efficient method for nuclear reprogramming
|
US20090226912A1
(en)
*
|
2007-12-21 |
2009-09-10 |
Wake Forest University Health Sciences |
Methods and compositions for correlating genetic markers with prostate cancer risk
|
US8986696B2
(en)
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
WO2009086425A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Fate Therapeutics, Inc. |
Methods for reprogramming cells to a pluripotent state and therapeutic applications related thereto
|
US20110014164A1
(en)
*
|
2008-02-15 |
2011-01-20 |
President And Fellows Of Harvard College |
Efficient induction of pluripotent stem cells using small molecule compounds
|
AU2009225665B9
(en)
|
2008-03-17 |
2015-01-15 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
KR101661940B1
(ko)
|
2008-05-02 |
2016-10-04 |
고쿠리츠 다이가쿠 호진 교토 다이가쿠 |
핵 초기화 방법
|
WO2009137624A2
(en)
*
|
2008-05-06 |
2009-11-12 |
Advanced Cell Technology, Inc. |
Hemangio colony forming cells and non-engrafting hemangio cells
|
KR20190000928A
(ko)
|
2008-05-06 |
2019-01-03 |
아스텔라스 인스티튜트 포 리제너러티브 메디슨 |
다능성 줄기세포로부터 유도된 탈핵 적혈구계 세포를 생산하는 방법
|
JP5733796B2
(ja)
*
|
2008-05-13 |
2015-06-10 |
ジェン−プロウブ インコーポレイテッド |
標的核酸配列の選択的ハイブリダイゼーションおよび捕捉における使用のため不活化可能型標的捕捉オリゴマー
|
DK2297307T3
(en)
|
2008-06-04 |
2016-07-25 |
Cellular Dynamics Int Inc |
PROCEDURES FOR THE MANUFACTURE OF IPS CELLS USING NON-VIRAL METHODS
|
US8669048B2
(en)
|
2008-06-24 |
2014-03-11 |
Parkinson's Institute |
Pluripotent cell lines and methods of use thereof
|
JP5688970B2
(ja)
*
|
2008-07-07 |
2015-03-25 |
タカラバイオ株式会社 |
多能性幹細胞の製造方法
|
AU2008360135A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Gifu University |
Efficient method for establishing induced pluripotent stem cells
|
CA2734128A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International, Inc. |
Methods for the production of ips cells
|
WO2010036923A1
(en)
*
|
2008-09-25 |
2010-04-01 |
Salk Institute For Biological Studies |
Induced pluripotent stem cells and methods of use
|
US20110262956A1
(en)
*
|
2008-10-07 |
2011-10-27 |
Guillermo Munoz Elias |
Co-culture compositions and methods
|
ES2959327T3
(es)
*
|
2008-10-24 |
2024-02-23 |
Wisconsin Alumni Res Found |
Células madre pluripotentes obtenidas mediante reprogramación no vírica
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
EP3312269A1
(en)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
CN101792776B
(zh)
*
|
2009-02-01 |
2013-12-11 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种高效诱导多能性干细胞的重组腺病毒载体、使用该载体的诱导方法及其用途
|
CA2753208C
(en)
*
|
2009-02-20 |
2018-08-21 |
Cellular Dynamics International, Inc. |
Methods and compositions for the differentiation of stem cells
|
CA2753845C
(en)
*
|
2009-02-27 |
2019-10-29 |
Kyoto University |
Nuclear reprogramming substance comprising glis1
|
CA2753679C
(en)
|
2009-02-27 |
2021-03-02 |
Cellular Dynamics International, Inc. |
Differentiation of pluripotent cells
|
WO2010115052A2
(en)
*
|
2009-04-03 |
2010-10-07 |
The Mclean Hospital Corporation |
Induced pluripotent stem cells
|
RU2399667C1
(ru)
*
|
2009-04-10 |
2010-09-20 |
Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" |
Способ получения плюрипотентных клеток
|
WO2010119819A1
(ja)
|
2009-04-17 |
2010-10-21 |
国立大学法人東北大学 |
ヒト肺組織幹細胞の調製方法及びヒト肺胞上皮細胞への分化誘導方法
|
CN101580816B
(zh)
*
|
2009-04-23 |
2012-02-29 |
中国科学院广州生物医药与健康研究院 |
诱导多能性干细胞快速高效产生的新型无血清培养基以及使用其的方法
|
JPWO2010131747A1
(ja)
*
|
2009-05-15 |
2012-11-08 |
国立大学法人 東京大学 |
ウイルス産生細胞
|
CA2764373C
(en)
|
2009-06-05 |
2019-11-19 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematophietic cells
|
KR20120099363A
(ko)
*
|
2009-06-19 |
2012-09-10 |
센터 오브 리제너러티브 메디신 오브 바르셀로나, 스페인 |
탯줄 혈액으로부터의 유도 만능 줄기 세포의 생성
|
US20120178158A1
(en)
*
|
2009-06-23 |
2012-07-12 |
The Scripps Research Institute |
Adult animals generated from induced pluripotent cells
|
JP5645197B2
(ja)
*
|
2009-06-23 |
2014-12-24 |
学校法人日本大学 |
幹細胞の未分化状態を維持する新規方法
|
JP2011004674A
(ja)
*
|
2009-06-26 |
2011-01-13 |
Fujitsu Ltd |
誘導多能性幹細胞(iPS細胞)の製造方法
|
WO2011005326A1
(en)
|
2009-07-09 |
2011-01-13 |
Massachusetts Institute Of Technology |
Methods and compositions for increased safety of stem cell-derived populations
|
US9550975B2
(en)
|
2009-07-15 |
2017-01-24 |
Mari Dezawa |
SSEA-3 pluripotent stem cell isolated from body tissue
|
WO2011019957A1
(en)
*
|
2009-08-12 |
2011-02-17 |
University Of Southern California |
Method for formation of induced pluripotent stem cells
|
JP5709015B2
(ja)
|
2009-08-19 |
2015-04-30 |
国立大学法人大阪大学 |
角膜移植用シート
|
US8883430B2
(en)
*
|
2009-08-21 |
2014-11-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells
|
WO2011031568A2
(en)
|
2009-08-27 |
2011-03-17 |
Synaptic Research, Llc |
A NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
|
WO2011032025A2
(en)
*
|
2009-09-10 |
2011-03-17 |
The Salk Institute For Biological Studies |
Adipose-derived induced pluripotent stem cells
|
CN102803476A
(zh)
*
|
2009-09-14 |
2012-11-28 |
程临钊 |
血细胞重编程产生多潜能干细胞和多功能干细胞
|
WO2011038002A1
(en)
*
|
2009-09-22 |
2011-03-31 |
Yale University |
Immunogenic epitopes as targets for universal cancer vaccines
|
SG10201406139RA
(en)
|
2009-09-30 |
2014-11-27 |
Agency Science Tech & Res |
A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells
|
EP3235901B1
(en)
*
|
2009-10-16 |
2022-12-21 |
The Scripps Research Institute |
Induction of pluripotent cells
|
JP2013507974A
(ja)
*
|
2009-10-29 |
2013-03-07 |
マックマスター ユニバーシティー |
線維芽細胞からの誘導多能性幹細胞および前駆細胞の作製法
|
WO2011053690A1
(en)
*
|
2009-10-30 |
2011-05-05 |
The University Of North Carolina At Chapel Hill |
Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
|
KR101775926B1
(ko)
|
2009-11-04 |
2017-09-07 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
화학 물질을 이용한 에피솜 재프로그래밍
|
WO2011059920A2
(en)
|
2009-11-10 |
2011-05-19 |
The J. David Gladstone Institutes |
Methods of generating neural stem cells
|
EP4166652A1
(en)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011063005A2
(en)
|
2009-11-17 |
2011-05-26 |
Advanced Cell Technology, Inc. |
Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
|
KR20120128605A
(ko)
|
2009-12-04 |
2012-11-27 |
스템 셀 앤드 리제너러티브 메디신 인터내셔날, 인크. |
기질 없는 조건 하에서 인간 배아줄기세포로부터 기능적 거핵구 및 혈소판의 대규모 생성
|
CN102648274B
(zh)
|
2009-12-09 |
2013-07-31 |
国立大学法人京都大学 |
包含双呋脒腙的促进多能干细胞分化成心肌细胞的组合物
|
CA2794473A1
(en)
|
2010-02-03 |
2011-08-11 |
National Cancer Center |
Induced hepatic stem cell and process for production thereof, and applications of the cell
|
JP6002581B2
(ja)
*
|
2010-02-05 |
2016-10-05 |
オークランド ユニサービシズ リミテッドAuckland Uniservices Limited |
細胞プログラミング
|
ES2623859T3
(es)
*
|
2010-03-04 |
2017-07-12 |
Miacom Diagnostics Gmbh |
FISH múltiple mejorada
|
CN102190731B
(zh)
*
|
2010-03-09 |
2016-01-27 |
中国科学院上海生命科学研究院 |
用人工转录因子诱导产生多能干细胞
|
JP5909482B2
(ja)
|
2010-03-31 |
2016-04-26 |
ザ スクリプス リサーチ インスティテュート |
細胞の再プログラム
|
US8802438B2
(en)
|
2010-04-16 |
2014-08-12 |
Children's Medical Center Corporation |
Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs
|
US8048675B1
(en)
|
2010-05-12 |
2011-11-01 |
Ipierian, Inc. |
Integration-free human induced pluripotent stem cells from blood
|
WO2011143415A1
(en)
|
2010-05-12 |
2011-11-17 |
Abt Holding Company |
Modulation of splenocytes in cell therapy
|
US9352003B1
(en)
|
2010-05-14 |
2016-05-31 |
Musculoskeletal Transplant Foundation |
Tissue-derived tissuegenic implants, and methods of fabricating and using same
|
US10130736B1
(en)
|
2010-05-14 |
2018-11-20 |
Musculoskeletal Transplant Foundation |
Tissue-derived tissuegenic implants, and methods of fabricating and using same
|
US8883210B1
(en)
|
2010-05-14 |
2014-11-11 |
Musculoskeletal Transplant Foundation |
Tissue-derived tissuegenic implants, and methods of fabricating and using same
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
US20130198876A1
(en)
*
|
2010-05-25 |
2013-08-01 |
National Cancer Center |
Induced malignant stem cells or pre-induction cancer stem cells capable of selfreplication outside of an organism, production method for same, and practical application for same
|
US9234180B2
(en)
|
2010-06-02 |
2016-01-12 |
Agency For Science, Technology And Research |
Method for inducing pluripotency in human somatic cells with PRDM14 or NFRKB
|
EP2580320B1
(en)
|
2010-06-14 |
2018-08-01 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
EP2397851B1
(fr)
*
|
2010-06-21 |
2015-01-07 |
Centre d'Etude des Cellules Souches |
Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines
|
US20120021445A1
(en)
*
|
2010-06-29 |
2012-01-26 |
Hogan Kirk J |
Pluripotent Stem Cells for Drug Induced Myopathy and Malignant Hyperthermia
|
JP2012029684A
(ja)
*
|
2010-06-30 |
2012-02-16 |
Cell Aid Kenkyusho:Kk |
細胞の製造方法
|
US9580689B2
(en)
|
2010-07-22 |
2017-02-28 |
Regents Of The University Of Minnesota |
Induced pluripotent stem cells
|
HUE054517T2
(hu)
*
|
2010-07-23 |
2021-09-28 |
Astellas Inst For Regenerative Medicine |
Eljárások sejtek ritka alpopulációinak detektálására és nagymértékben tisztított sejtkészítmények
|
US9394523B2
(en)
|
2010-08-22 |
2016-07-19 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
US9499790B2
(en)
|
2010-08-26 |
2016-11-22 |
Kyoto University |
Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
|
WO2012027486A2
(en)
*
|
2010-08-26 |
2012-03-01 |
The Regents Of The University Of California |
Methods and compositions for generation of induced pluripotent stem cells by rnaa
|
WO2012026491A1
(ja)
|
2010-08-26 |
2012-03-01 |
国立大学法人京都大学 |
多能性幹細胞の心筋分化促進剤
|
US8068011B1
(en)
|
2010-08-27 |
2011-11-29 |
Q Street, LLC |
System and method for interactive user-directed interfacing between handheld devices and RFID media
|
US9732389B2
(en)
|
2010-09-03 |
2017-08-15 |
Wake Forest University Health Sciences |
Methods and compositions for correlating genetic markers with prostate cancer risk
|
JP2013545439A
(ja)
|
2010-09-17 |
2013-12-26 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
多能性幹細胞の有用性および安全性の特徴決定を行うための機能的ゲノミクスアッセイ
|
EP2630232A4
(en)
|
2010-10-22 |
2014-04-02 |
Biotime Inc |
METHOD FOR MODIFYING TRANSCRIPTIONAL REGULATORY NETWORKS IN STEM CELLS
|
AU2011349446C1
(en)
|
2010-12-22 |
2016-01-21 |
Fate Therapauetics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
WO2012092379A2
(en)
|
2010-12-29 |
2012-07-05 |
Sigma-Aldrich Co. Llc |
Cells having disrupted expression of proteins involved in adme and toxicology processes
|
US20120252122A1
(en)
*
|
2011-01-05 |
2012-10-04 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing production of induced pluripotent stem cells (ipscs)
|
US9534256B2
(en)
|
2011-01-06 |
2017-01-03 |
Wake Forest University Health Sciences |
Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
|
US9850466B2
(en)
|
2011-01-19 |
2017-12-26 |
The Regents Of The University Of California |
Somatic cells with innate potential for pluripotency
|
WO2012112458A2
(en)
*
|
2011-02-14 |
2012-08-23 |
The Regents Of The University Of California |
Compositions and methods for increasing reprogramming efficiency
|
US9228204B2
(en)
|
2011-02-14 |
2016-01-05 |
University Of Utah Research Foundation |
Constructs for making induced pluripotent stem cells
|
TWI445301B
(zh)
*
|
2011-03-03 |
2014-07-11 |
Realtek Semiconductor Corp |
傳送/接收電路以及傳送/接收電路阻抗校正方法
|
US8834928B1
(en)
|
2011-05-16 |
2014-09-16 |
Musculoskeletal Transplant Foundation |
Tissue-derived tissugenic implants, and methods of fabricating and using same
|
EP2710041A4
(en)
|
2011-05-18 |
2014-11-05 |
Parkinson S Inst |
ASSAY FOR DETERMINING LRRK2 ACTIVITY IN MORBUS PARKINSON
|
US10731134B2
(en)
|
2011-05-27 |
2020-08-04 |
Public University Corporation Yokohama City University |
Production method for artificial cancer stem cell and induced differentiation method therefor
|
WO2012174467A2
(en)
*
|
2011-06-15 |
2012-12-20 |
Salk Institute For Biological Studies |
Cord blood-derived neurons by expression of sox2
|
US9395354B2
(en)
|
2011-07-21 |
2016-07-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof
|
EP2737064B1
(en)
|
2011-07-25 |
2017-12-06 |
Kyoto University |
Method for screening induced pluripotent stem cells
|
WO2013018851A1
(ja)
*
|
2011-08-02 |
2013-02-07 |
独立行政法人国立がん研究センター |
誘導肝幹細胞から肝分化誘導する方法及び誘導肝前駆細胞
|
EP2756092A4
(en)
*
|
2011-09-16 |
2015-10-28 |
Giovanni Amabile |
METHOD FOR THE PRODUCTION OF CELLS, TISSUE AND ANTIBODIES
|
CN102329769B
(zh)
*
|
2011-09-28 |
2013-07-31 |
浙江大学 |
一种获得造血干细胞的方法
|
WO2013055397A1
(en)
|
2011-10-14 |
2013-04-18 |
Children's Medical Center Corporation |
Inhibition and enhancement of reprogramming by chromatin modifying enzymes
|
WO2013058403A1
(ja)
|
2011-10-21 |
2013-04-25 |
国立大学法人京都大学 |
層流による多能性維持単一分散細胞培養法
|
GB2496375A
(en)
|
2011-10-28 |
2013-05-15 |
Kymab Ltd |
A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
|
US20140329317A1
(en)
|
2011-11-25 |
2014-11-06 |
Kyoto University |
Method for culturing pluripotent stem cell
|
CN104080907A
(zh)
|
2011-11-30 |
2014-10-01 |
日本国立癌症研究中心 |
诱导恶性干细胞
|
BR112014013152B1
(pt)
|
2011-12-01 |
2021-08-31 |
New York Stem Cell Foundation, Inc |
Sistema automatizado para geração de células-tronco pluripotentes induzidas (ipscs)
|
US10428309B2
(en)
|
2011-12-01 |
2019-10-01 |
New York Stem Cell Foundation, Inc. |
Systems and methods for producing stem cells and differentiated cells
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
KR20210134808A
(ko)
|
2011-12-05 |
2021-11-10 |
팩터 바이오사이언스 인크. |
세포를 형질감염시키는 방법들 및 생성물들
|
JP6274510B2
(ja)
|
2012-01-27 |
2018-02-07 |
国立大学法人京都大学 |
多能性幹細胞の心筋分化誘導法
|
IN2014DN08862A
(zh)
*
|
2012-03-28 |
2015-05-22 |
Quarrymen Corp |
|
US9447378B2
(en)
|
2012-04-27 |
2016-09-20 |
Massachusetts Institute Of Technology |
Method for differentiating human embryonic stem cells into β-cells for the treatment of type I diabetes
|
US10119150B2
(en)
*
|
2012-05-13 |
2018-11-06 |
Allele Biotechnology & Pharmaceuticals, Inc. |
Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA
|
US10155929B2
(en)
*
|
2012-05-13 |
2018-12-18 |
Allele Biotechnology & Pharmaceuticals, Inc. |
Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
|
PE20150336A1
(es)
|
2012-05-25 |
2015-03-25 |
Univ California |
Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn
|
CN114652816A
(zh)
|
2012-07-11 |
2022-06-24 |
组织技术公司 |
含有hc-ha/ptx3复合物的组合物及其使用方法
|
US9175263B2
(en)
*
|
2012-08-22 |
2015-11-03 |
Biotime, Inc. |
Methods and compositions for targeting progenitor cell lines
|
WO2014031085A1
(en)
*
|
2012-08-24 |
2014-02-27 |
Agency For Science, Technology And Research |
The use of pdgf-bb in a method of enhancing the efficiency of reprogramming of a somatic cell to a pluripotent stem cell
|
JP2015530122A
(ja)
*
|
2012-10-05 |
2015-10-15 |
チルドレンズ ホスピタル メディカル センター |
脂腺細胞の培養及び使用方法
|
WO2014088932A1
(en)
*
|
2012-12-03 |
2014-06-12 |
Anthrogenesis Corporation |
Treatment of schizophrenia using amnion derived adherent cells
|
ES2896354T3
(es)
|
2012-12-21 |
2022-02-24 |
Astellas Inst For Regenerative Medicine |
Métodos para la producción de plaquetas a partir de células madre pluripotentes
|
EP2934548A2
(en)
*
|
2012-12-24 |
2015-10-28 |
Ramot at Tel-Aviv University Ltd |
Agents for treating genetic diseases resulting from nonsense mutations, and methods for identifying the same
|
JP6433902B2
(ja)
*
|
2013-01-04 |
2018-12-05 |
国立大学法人京都大学 |
初期化幹細胞
|
US9709554B2
(en)
|
2013-01-31 |
2017-07-18 |
Rutgers, The State University Of New Jersey |
In vitro model of macrosteatotic (fatty) liver
|
CN107362357B
(zh)
|
2013-02-06 |
2021-04-27 |
Nc医学研究公司 |
用于治疗神经变性的细胞疗法
|
US10450546B2
(en)
|
2013-02-06 |
2019-10-22 |
University Of Rochester |
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
|
US20160002599A1
(en)
|
2013-02-08 |
2016-01-07 |
Kyoto University |
Production methods for megakaryocytes and platelets
|
US20140248696A1
(en)
*
|
2013-03-01 |
2014-09-04 |
Wisconsin Alumni Research Foundation |
Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors
|
US10160950B2
(en)
|
2013-03-01 |
2018-12-25 |
Wisconsin Alumni Research Foundation |
Methods of maintaining, expanding and differentiating neuronal subtype specific progenitors
|
JP6292415B2
(ja)
|
2013-03-06 |
2018-03-14 |
国立大学法人京都大学 |
多能性幹細胞の培養システム及び多能性幹細胞の継代方法
|
US10196609B2
(en)
|
2013-03-08 |
2019-02-05 |
Kyoto University |
Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
WO2014143383A1
(en)
|
2013-03-13 |
2014-09-18 |
Agilent Technologies, Inc. |
Transposome tethered to a gene delivery vehicle
|
CA3143449A1
(en)
|
2013-03-14 |
2014-09-25 |
The Regents Of The University Of California |
In vitro production of medial ganglionic eminence precursor cells
|
KR20160048029A
(ko)
*
|
2013-03-15 |
2016-05-03 |
마르쿠스 카레 토를레이프 라르손 |
제대혈 수집 및 세포의 분리를 위한 세포, 방법 및 장치
|
US20160237400A1
(en)
*
|
2013-03-15 |
2016-08-18 |
The Jackson Laboratory |
Isolation of non-embryonic stem cells and uses thereof
|
JP6473077B2
(ja)
|
2013-03-21 |
2019-02-20 |
国立大学法人京都大学 |
神経分化誘導用の多能性幹細胞
|
US10072242B2
(en)
|
2013-03-25 |
2018-09-11 |
Foundation For Biomedical Research And Innovation At Kobe |
Cell sorting method
|
CA2909230C
(en)
|
2013-04-12 |
2021-06-15 |
Kyoto University |
Method for inducing alveolar epithelial progenitor cells
|
WO2014172616A2
(en)
*
|
2013-04-18 |
2014-10-23 |
President And Fellows Of Harvard College |
Methods, compositions and kits for promoting motor neuron survival and treating and diagnosing neurodegenerative disorders
|
WO2014185358A1
(ja)
|
2013-05-14 |
2014-11-20 |
国立大学法人京都大学 |
効率的な心筋細胞の誘導方法
|
WO2014192909A1
(ja)
|
2013-05-31 |
2014-12-04 |
iHeart Japan株式会社 |
ハイドロゲルを組み込んだ積層化細胞シート
|
ES2791598T3
(es)
|
2013-06-05 |
2020-11-05 |
Bellicum Pharmaceuticals Inc |
Métodos para inducir apoptosis parcial utilizando polipéptidos de caspasa
|
CA2914615C
(en)
|
2013-06-05 |
2023-10-17 |
Biotime, Inc. |
Compositions and methods for induced tissue regeneration in mammalian species
|
WO2014200905A2
(en)
|
2013-06-10 |
2014-12-18 |
President And Fellows Of Harvard College |
Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
|
BR112015030918A2
(pt)
|
2013-06-11 |
2017-12-05 |
Astellas Pharma Inc |
método para produção de células progenitoras renais, e fármacos contendo células progenitoras renais
|
JP6502255B2
(ja)
*
|
2013-06-12 |
2019-04-17 |
株式会社 資生堂 |
Pdgfを含有するds細胞用無血清培地
|
WO2014201431A1
(en)
|
2013-06-14 |
2014-12-18 |
Massachusetts Institute Of Technology |
Articles and methods for stem cell differentiation
|
WO2014210533A1
(en)
*
|
2013-06-27 |
2014-12-31 |
The New York Stem Cell Foundation |
Improved systems and methods for producing stem cells and differentiated cells
|
WO2015006725A2
(en)
|
2013-07-12 |
2015-01-15 |
Cedars-Sinai Medical Center |
Generation of induced pluripotent stem cells from normal human mammary epithelial cells
|
US20150024406A1
(en)
*
|
2013-07-17 |
2015-01-22 |
Robin N. Coger-Simmons |
Increased aquaporin expression on cellular membrane to improve cryopreservation efficiency
|
MX2016001247A
(es)
|
2013-07-30 |
2016-08-17 |
Musculoskeletal Transplant Foundation |
Matrices derivadas de tejido suave acelular y metodos para preparar las mismas.
|
US9796962B2
(en)
|
2013-08-07 |
2017-10-24 |
Kyoto University |
Method for generating pancreatic hormone-producing cells
|
EP2840132B1
(en)
|
2013-08-22 |
2016-11-30 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin |
Method for producing Engineered Heart Muscle (EHM)
|
EP3042951B1
(en)
|
2013-09-05 |
2019-02-20 |
Kyoto University |
New method for inducing dopamine-producing neural precursor cells
|
JP6611170B2
(ja)
|
2013-09-12 |
2019-11-27 |
株式会社カネカ |
人工多能性幹細胞の分化誘導方法及び選別方法
|
JP6333830B2
(ja)
|
2013-09-13 |
2018-05-30 |
国立大学法人京都大学 |
多能性幹細胞の心筋分化を促進する化合物
|
US10745668B2
(en)
|
2013-09-20 |
2020-08-18 |
Lonza Ltd |
Methods for nuclear reprogramming of cells
|
JP6681825B2
(ja)
*
|
2013-09-20 |
2020-04-15 |
レパイロン・ゲーエムベーハーRepairon Gmbh |
多能性幹細胞から機能的心筋へと直接分化させる方法
|
CN104450609B
(zh)
*
|
2013-09-25 |
2017-07-14 |
深圳华大基因科技有限公司 |
一种分离和培养脐带间充质干细胞的方法
|
WO2015058117A1
(en)
*
|
2013-10-18 |
2015-04-23 |
Icahn School Of Medicine At Mount Sinai |
Directed cardiomyocyte differentiation and ventricular specification of stem cells
|
WO2015061568A1
(en)
*
|
2013-10-23 |
2015-04-30 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Reprogramming cardiomyocytes with one transcription factor
|
US10100283B2
(en)
|
2013-11-01 |
2018-10-16 |
Kyoto University |
Efficient chondrocyte induction method
|
WO2015069736A1
(en)
|
2013-11-08 |
2015-05-14 |
The Mclean Hospital Corporation |
METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS
|
US9932607B2
(en)
|
2013-11-15 |
2018-04-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Site-specific integration of transgenes into human cells
|
CA2930877A1
(en)
|
2013-11-18 |
2015-05-21 |
Crispr Therapeutics Ag |
Crispr-cas system materials and methods
|
CA2933083A1
(en)
|
2013-12-11 |
2015-06-18 |
Pfizer Limited |
Method for producing retinal pigment epithelial cells
|
US9994831B2
(en)
|
2013-12-12 |
2018-06-12 |
The Regents Of The University Of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
US9512406B2
(en)
|
2013-12-20 |
2016-12-06 |
The J. David Gladstone Institute, a testamentary trust established under the Will of J. David Gladstone |
Generating hepatocytes
|
US11078462B2
(en)
|
2014-02-18 |
2021-08-03 |
ReCyte Therapeutics, Inc. |
Perivascular stromal cells from primate pluripotent stem cells
|
EP3805369A1
(en)
|
2014-03-04 |
2021-04-14 |
Fate Therapeutics, Inc. |
Improved reprogramming methods and cell culture platforms
|
JP2017513517A
(ja)
*
|
2014-03-19 |
2017-06-01 |
ブイセル セラピューティックス,インコーポレイテッド |
多能性細胞に関連する方法
|
EP3142790B8
(en)
|
2014-05-14 |
2019-04-24 |
Hooke Bio Limited |
Method for handling fluid in a microfluidic device with channel plates
|
JP6651218B2
(ja)
|
2014-05-30 |
2020-02-19 |
国立大学法人京都大学 |
低分子化合物を用いた多能性幹細胞の心筋分化誘導法
|
US20170107498A1
(en)
*
|
2014-06-05 |
2017-04-20 |
Cedars-Sinai Medical Center |
Novel and efficient method for reprogramming immortalized lymphoblastoid cell lines to induced pluripotent stem cells
|
US10240127B2
(en)
|
2014-07-03 |
2019-03-26 |
ReCyte Therapeutics, Inc. |
Exosomes from clonal progenitor cells
|
EP3170901B1
(en)
|
2014-07-14 |
2021-06-02 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing dendritic cells from stem cells
|
WO2016036754A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Methods and compositions for rna-directed target dna modification
|
EP3206498A4
(en)
*
|
2014-10-15 |
2018-03-28 |
Coyne Scientific, LLC |
Methods for conducting stimulus-response studies with induced pluripotent stem cells derived from perinatal cells or tissues
|
EP3215522B1
(en)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
AU2015353853B2
(en)
|
2014-11-25 |
2020-10-15 |
President And Fellows Of Harvard College |
Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
|
WO2016088243A1
(ja)
*
|
2014-12-05 |
2016-06-09 |
株式会社ニコン |
判定装置、観察システム、観察方法、そのプログラム、細胞の製造方法、および細胞
|
JP7253692B2
(ja)
|
2014-12-26 |
2023-04-07 |
国立大学法人京都大学 |
肝細胞誘導方法
|
US11241505B2
(en)
|
2015-02-13 |
2022-02-08 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
EP3259348A4
(en)
|
2015-02-17 |
2018-07-18 |
University Health Network |
Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
|
JP2016202172A
(ja)
|
2015-04-16 |
2016-12-08 |
国立大学法人京都大学 |
疑似膵島の製造方法
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
EP3297694A1
(en)
|
2015-05-21 |
2018-03-28 |
Musculoskeletal Transplant Foundation |
Modified demineralized cortical bone fibers
|
EP3302048B1
(en)
*
|
2015-05-29 |
2020-02-19 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a disruption in a c9orf72 locus
|
US10883086B2
(en)
|
2015-07-06 |
2021-01-05 |
University Of Georgia Research Foundation, Inc. |
Methods and compositions related to increased influenza virus production
|
US10912864B2
(en)
|
2015-07-24 |
2021-02-09 |
Musculoskeletal Transplant Foundation |
Acellular soft tissue-derived matrices and methods for preparing same
|
EP3332020B1
(en)
*
|
2015-08-07 |
2023-12-20 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Method of determining cellular protein homeostasis
|
US11052175B2
(en)
|
2015-08-19 |
2021-07-06 |
Musculoskeletal Transplant Foundation |
Cartilage-derived implants and methods of making and using same
|
US11286454B2
(en)
|
2015-08-31 |
2022-03-29 |
I Peace, Inc. |
Pluripotent stem cell manufacturing system and method for producing induced pluripotent stem cells
|
DK3344758T3
(da)
|
2015-09-01 |
2021-11-01 |
Ncardia B V |
Fremgangsmåde in vitro til differentiering af en human pluripotent stamcellepopulation i en kardiomyocytcellepopulation
|
EP3353297A1
(en)
|
2015-09-24 |
2018-08-01 |
Crispr Therapeutics AG |
Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
|
WO2017059566A1
(zh)
*
|
2015-10-08 |
2017-04-13 |
高雄医学大学 |
一种快速分离脂肪间质细胞的组合物
|
AU2016338680B2
(en)
*
|
2015-10-16 |
2022-11-17 |
Fate Therapeutics, Inc. |
Platform for the induction and maintenance of ground state pluripotency
|
CN108348556A
(zh)
*
|
2015-11-02 |
2018-07-31 |
欧瑞3恩公司 |
细胞周期阻滞提高产生诱导多能干细胞的效率
|
WO2017100683A1
(en)
*
|
2015-12-09 |
2017-06-15 |
Stemgenics, Inc. |
Differential drug screening using pluripotent stem cells induced with functionalized nanoparticles
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
US11359242B2
(en)
|
2016-01-07 |
2022-06-14 |
Cedars-Sinai Medical Center |
Method to identify key markers of human pluripotent cell-derived somatic cells that predict molecular similarity to in vivo target cells
|
CA3013357A1
(en)
|
2016-02-01 |
2017-08-10 |
Cedars-Sinai Medical Center |
Systems and methods for growth of intestinal cells in microfluidic devices
|
EP3417061B1
(en)
|
2016-02-18 |
2022-10-26 |
The Regents of the University of California |
Methods and compositions for gene editing in stem cells
|
EP3431584B1
(en)
|
2016-03-18 |
2023-06-28 |
Kyoto University |
Methods for freezing an aggregate of pluripotent stem cell-derived cardiomyocytes
|
WO2017164746A1
(en)
|
2016-03-25 |
2017-09-28 |
Pluriomics B.V. |
In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes
|
PT3444334T
(pt)
|
2016-04-15 |
2021-09-08 |
Univ Kyoto |
Método para induzir células t cd8 positivas específicas de antigénio
|
EP3447130A4
(en)
|
2016-04-22 |
2019-11-13 |
Kyoto University |
METHOD FOR PRODUCING DOPAMINE-PROPERING NEURAL PRESERVATOR CELLS
|
EP3455346A1
(en)
|
2016-05-12 |
2019-03-20 |
Erasmus University Medical Center Rotterdam |
A method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium
|
US10221395B2
(en)
|
2016-06-16 |
2019-03-05 |
Cedars-Sinai Medical Center |
Efficient method for reprogramming blood to induced pluripotent stem cells
|
US11572545B2
(en)
|
2016-06-16 |
2023-02-07 |
Cedars-Sinai Medical Center |
Efficient method for reprogramming blood to induced pluripotent stem cells
|
US20190330603A1
(en)
|
2016-06-17 |
2019-10-31 |
Genesis Technologies Limited |
Crispr-cas system, materials and methods
|
MX2018016055A
(es)
*
|
2016-06-23 |
2019-07-04 |
Tithon Biotech Inc |
Células que expresan receptor de hormona paratiroidea 1 y usos de las mismas.
|
US11103537B2
(en)
|
2016-06-23 |
2021-08-31 |
Tithon Biotech Inc. |
Cells expressing parathyroid hormone 1 receptor and uses thereof
|
JP2019528284A
(ja)
|
2016-08-17 |
2019-10-10 |
ファクター バイオサイエンス インコーポレイテッド |
核酸産物およびその投与方法
|
US11542473B2
(en)
|
2016-10-21 |
2023-01-03 |
Amniotics Ab |
Methods and compositions for generating hematopoietic cells
|
WO2018124118A1
(ja)
|
2016-12-27 |
2018-07-05 |
住友化学株式会社 |
人工多能性幹細胞の評価方法及び選抜方法、並びに人工多能性幹細胞の製造方法
|
EP4053268A3
(en)
|
2017-01-20 |
2022-12-07 |
Kyoto University |
Method for producing cd8alpha+beta+cytotoxic t cells
|
CA3051583A1
(en)
*
|
2017-01-25 |
2018-08-02 |
Whitehead Institute For Biomedical Research |
Methods for building genomic networks and uses thereof
|
US11913022B2
(en)
|
2017-01-25 |
2024-02-27 |
Cedars-Sinai Medical Center |
In vitro induction of mammary-like differentiation from human pluripotent stem cells
|
EP3575392A4
(en)
|
2017-01-26 |
2020-08-26 |
Osaka University |
MEDIUM FOR INDUCING THE DIFFERENTIATION OF STEM CELLS INTO MESODERMAL CELLS AND METHOD FOR PRODUCING MESODERMAL CELLS
|
US10828330B2
(en)
|
2017-02-22 |
2020-11-10 |
IO Bioscience, Inc. |
Nucleic acid constructs comprising gene editing multi-sites and uses thereof
|
US20190390169A1
(en)
|
2017-03-03 |
2019-12-26 |
Kyoto University |
Pancreatic progenitor cell production method
|
WO2018170139A1
(en)
*
|
2017-03-14 |
2018-09-20 |
EMULATE, Inc. |
Neuromuscular junction: nmj-on-chip
|
US11559548B2
(en)
|
2017-03-14 |
2023-01-24 |
Kyoto University |
Method for producing helper T cells from pluripotent stem cells
|
US11767513B2
(en)
|
2017-03-14 |
2023-09-26 |
Cedars-Sinai Medical Center |
Neuromuscular junction
|
US11414648B2
(en)
|
2017-03-24 |
2022-08-16 |
Cedars-Sinai Medical Center |
Methods and compositions for production of fallopian tube epithelium
|
US10767164B2
(en)
|
2017-03-30 |
2020-09-08 |
The Research Foundation For The State University Of New York |
Microenvironments for self-assembly of islet organoids from stem cells differentiation
|
CA3064830A1
(en)
|
2017-05-25 |
2018-11-29 |
Kyoto University |
Method for inducing differentiation of intermediate mesodermal cell to renal progenitor cell, and method for inducing differentiation of pluripotent stem cell to renal progenitor cell
|
EP3640318A4
(en)
|
2017-06-14 |
2021-03-17 |
Takeda Pharmaceutical Company Limited |
CELL SEALING DEVICE
|
CN111164209A
(zh)
|
2017-06-19 |
2020-05-15 |
公益财团法人神户医疗产业都市推进机构 |
多能干细胞的分化能力的预测方法和用于该预测方法的试剂
|
JP6758631B2
(ja)
|
2017-06-19 |
2020-09-23 |
国立大学法人大阪大学 |
角膜内皮細胞マーカー及びその利用
|
NL2019517B1
(en)
|
2017-09-08 |
2019-03-19 |
Univ Erasmus Med Ct Rotterdam |
New therapy for Pompe disease
|
JP7140400B2
(ja)
|
2017-10-17 |
2022-09-21 |
国立大学法人京都大学 |
多能性幹細胞から人工神経筋接合部を得る方法
|
WO2019092507A2
(en)
|
2017-11-09 |
2019-05-16 |
Crispr Therapeutics Ag |
Crispr/cas systems for treatment of dmd
|
WO2019099725A1
(en)
|
2017-11-15 |
2019-05-23 |
Semma Therapeutics, Inc. |
Islet cell manufacturing compositions and methods of use
|
TW201940693A
(zh)
|
2017-11-30 |
2019-10-16 |
國立大學法人京都大學 |
細胞之培養方法
|
KR102137884B1
(ko)
*
|
2017-12-12 |
2020-07-24 |
순천향대학교 산학협력단 |
타우로우루소디옥시콜린산을 포함하는 고효율 세포전환용 배지 첨가제
|
KR102137883B1
(ko)
*
|
2017-12-12 |
2020-07-24 |
순천향대학교 산학협력단 |
페닐부틸산나트륨을 포함하는 고효율 세포전환용 배지 첨가제
|
CA3084825A1
(en)
|
2017-12-14 |
2019-06-20 |
Crispr Therapeutics Ag |
Novel rna-programmable endonuclease systems and their use in genome editing and other applications
|
CN111868224A
(zh)
|
2017-12-22 |
2020-10-30 |
国立大学法人京都大学 |
细胞培养装置,培养液抽吸器及细胞培养方法
|
WO2019165320A1
(en)
*
|
2018-02-22 |
2019-08-29 |
Celularity, Inc. |
Post partum tissue-derived induced pluripotent stem cells and uses thereof
|
US20210060210A1
(en)
|
2018-03-19 |
2021-03-04 |
Kyoto University |
Hydrogel capsule
|
WO2019183150A1
(en)
|
2018-03-19 |
2019-09-26 |
Casebia Therapeutics Limited Liability Partnership |
Novel rna-programmable endonuclease systems and uses thereof
|
KR102209108B1
(ko)
*
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
WO2019189553A1
(ja)
|
2018-03-30 |
2019-10-03 |
国立大学法人京都大学 |
複素環化合物
|
US20210054406A1
(en)
|
2018-03-30 |
2021-02-25 |
Kyoto University |
Cell production method
|
US20210009956A1
(en)
|
2018-03-30 |
2021-01-14 |
Kyoto University |
Cardiomyocyte maturation promoter
|
WO2019195800A1
(en)
|
2018-04-06 |
2019-10-10 |
Cedars-Sinai Medical Center |
Novel differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells
|
CN112313327B
(zh)
|
2018-04-23 |
2024-04-19 |
千纸鹤治疗公司 |
增殖抑制剂
|
US20210254006A1
(en)
|
2018-06-06 |
2021-08-19 |
Ideaya Biosciences, Inc. |
Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
|
US20210246422A1
(en)
*
|
2018-06-14 |
2021-08-12 |
Academia Sinica |
Method to generate induced oligodendrocyte-lineage cells and treatment using such cells
|
EP3806861A1
(en)
|
2018-06-18 |
2021-04-21 |
University of Rochester |
Methods of treating schizophrenia and other neuropsychiatric disorders
|
CA3103675A1
(en)
|
2018-06-21 |
2019-12-26 |
University Of Rochester |
Methods of treating or inhibiting onset of huntington's disease
|
EP3822342A4
(en)
|
2018-07-13 |
2022-08-03 |
Kyoto University |
PROCESS FOR PRODUCTION OF GAMMA DELTA T LYMPHOCYTES
|
US20210299331A1
(en)
|
2018-07-19 |
2021-09-30 |
Kyoto University |
Pluripotent stem cell-derived plate-shaped cartilage and method for producing the same
|
WO2020022261A1
(ja)
|
2018-07-23 |
2020-01-30 |
国立大学法人京都大学 |
新規腎前駆細胞マーカーおよびそれを利用した腎前駆細胞の濃縮方法
|
EP3831931A4
(en)
|
2018-08-03 |
2022-05-18 |
Kyoto University |
CELL PRODUCTION PROCESS
|
CN112639111B
(zh)
|
2018-08-10 |
2023-07-21 |
国立大学法人京都大学 |
使用阳离子性脂质的转染心肌细胞的方法
|
CN112567025A
(zh)
|
2018-08-10 |
2021-03-26 |
国立大学法人京都大学 |
Cd3阳性细胞的制造方法
|
AU2019320072A1
(en)
|
2018-08-10 |
2021-02-25 |
Vertex Pharmaceuticals Incorporated |
Stem cell derived islet differentiation
|
CN112585262B
(zh)
|
2018-08-22 |
2023-10-20 |
国立大学法人京都大学 |
肠神经前体细胞的制造方法
|
EA202190624A1
(ru)
|
2018-08-31 |
2021-06-09 |
Нойл-Иммьюн Байотек, Инк. |
Car-экспрессирующие т-клетки и car-экспрессирующий вектор
|
TW202026420A
(zh)
|
2018-09-19 |
2020-07-16 |
日商武田藥品工業股份有限公司 |
胰島素產生細胞
|
EP3868869A4
(en)
|
2018-10-15 |
2022-08-03 |
Public University Corporation Yokohama City University |
NUTRITIONAL COMPOSITION
|
WO2020116606A1
(ja)
|
2018-12-06 |
2020-06-11 |
キリンホールディングス株式会社 |
T細胞又はnk細胞の製造方法、t細胞又はnk細胞の培養用培地、t細胞又はnk細胞の培養方法、未分化t細胞の未分化状態を維持する方法及びt細胞又はnk細胞の増殖促進剤
|
CN113728103A
(zh)
|
2018-12-11 |
2021-11-30 |
罗切斯特大学 |
治疗精神分裂症和其他神经精神病症的方法
|
JP7449291B2
(ja)
|
2018-12-20 |
2024-03-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヌクレアーゼ媒介リピート伸長
|
EP3900787A4
(en)
|
2018-12-21 |
2022-02-23 |
Kyoto University |
CARTILAGE-LIKE TISSUE WITH LOCALIZED LUBRICINE, METHOD FOR THE PRODUCTION THEREOF, AND COMPOSITION COMPRISING IT FOR THE TREATMENT OF ARTICULAR CARTILAGE LESIONS
|
SG11202106673XA
(en)
*
|
2018-12-21 |
2021-07-29 |
I Peace Inc |
Health risk information management device, health risk information management method, and program
|
US20220062341A1
(en)
|
2018-12-26 |
2022-03-03 |
Kirin Holdings Kabushiki Kaisha |
Modified tcr and production method therefor
|
TW202039543A
(zh)
|
2018-12-27 |
2020-11-01 |
國立大學法人京都大學 |
T細胞受體的變體
|
WO2020158914A1
(ja)
|
2019-02-01 |
2020-08-06 |
国立大学法人京都大学 |
細胞の検出方法
|
US20230057355A1
(en)
|
2019-02-13 |
2023-02-23 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
AU2020231380A1
(en)
|
2019-03-07 |
2021-09-23 |
The Regents Of The University Of California |
CRISPR-Cas effector polypeptides and methods of use thereof
|
WO2020209959A1
(en)
|
2019-03-08 |
2020-10-15 |
Crispr Therapeutics Ag |
Nucleobase-editing fusion protein systems, compositions, and uses thereof
|
US20220145274A1
(en)
|
2019-03-12 |
2022-05-12 |
Crispr Therapeutics Ag |
Novel high fidelity rna-programmable endonuclease systems and uses thereof
|
EP3950953A4
(en)
|
2019-03-29 |
2023-04-19 |
Public University Corporation Yokohama City University |
SCREENING PROCEDURES AND TOXICITY ASSESSMENT PROCEDURES
|
CA3136401A1
(en)
|
2019-04-10 |
2020-10-15 |
Orizuru Therapeutics, Inc. |
Method for producing biological tissue-like structure
|
US20210047649A1
(en)
|
2019-05-08 |
2021-02-18 |
Vertex Pharmaceuticals Incorporated |
Crispr/cas all-in-two vector systems for treatment of dmd
|
WO2020235319A1
(ja)
|
2019-05-20 |
2020-11-26 |
味の素株式会社 |
軟骨又は骨の前駆細胞の拡大培養方法
|
EP3985104A4
(en)
|
2019-06-11 |
2023-04-12 |
Kyoto University |
PROCEDURE FOR GENERATING A KIDNEY INTERSTITIAL CELL
|
EP3990624A1
(en)
|
2019-06-25 |
2022-05-04 |
Vertex Pharmaceuticals Incorporated |
Enhanced differentiation of beta cells
|
CN110257334A
(zh)
*
|
2019-07-24 |
2019-09-20 |
安徽科门生物科技有限公司 |
一种神经干细胞培养基以及培养方法
|
US10501404B1
(en)
|
2019-07-30 |
2019-12-10 |
Factor Bioscience Inc. |
Cationic lipids and transfection methods
|
WO2021030424A1
(en)
|
2019-08-13 |
2021-02-18 |
Semma Therapeutics, Inc. |
Pancreatic differentiation
|
CA3151819A1
(en)
|
2019-08-20 |
2021-02-25 |
Orizuru Therapeutics, Inc. |
Method for enriching cardiac myocytes
|
WO2021076043A1
(en)
|
2019-10-18 |
2021-04-22 |
Amniotics Ab |
Use of term amniotic fluid cells for the treatment of acute and chronic respiratory diseases
|
JPWO2021079874A1
(zh)
|
2019-10-21 |
2021-04-29 |
|
|
TWI769410B
(zh)
*
|
2019-10-28 |
2022-07-01 |
中國醫藥大學 |
新穎誘導性多能幹細胞(ipscs)及其應用
|
US11760980B2
(en)
|
2019-10-28 |
2023-09-19 |
China Medical University |
Induced pluripotent stem cells (IPSCS) and applications thereof
|
CN114729318A
(zh)
|
2019-11-01 |
2022-07-08 |
国立大学法人京都大学 |
T细胞的制备方法
|
US20230000915A1
(en)
|
2019-11-25 |
2023-01-05 |
Kyoto University |
T-cell master cell bank
|
CN115023233A
(zh)
|
2019-12-12 |
2022-09-06 |
国立大学法人千叶大学 |
包含巨核细胞和血小板的冷冻干燥制剂
|
CN114929250A
(zh)
*
|
2019-12-18 |
2022-08-19 |
爱迪塔斯医药公司 |
用于疗法的经工程化的细胞
|
EP4087914A1
(en)
|
2020-01-09 |
2022-11-16 |
Herophilus, Inc. |
Methods and compositions of pro-organ formation on particle substrates and uses thereof
|
EP4103045A1
(en)
*
|
2020-02-16 |
2022-12-21 |
Genetikaplus Ltd. |
Methods of therapeutic prognostication
|
JP2023516632A
(ja)
|
2020-02-28 |
2023-04-20 |
武田薬品工業株式会社 |
多能性幹細胞からナチュラルキラー細胞を産生するための方法
|
CN115885035A
(zh)
|
2020-03-19 |
2023-03-31 |
千纸鹤治疗公司 |
心肌细胞的精制方法
|
JPWO2021187602A1
(zh)
|
2020-03-19 |
2021-09-23 |
|
|
EP4130253A4
(en)
|
2020-03-31 |
2024-05-29 |
Univ Kyoto |
METHOD FOR PRODUCING T-CELL PRECURSORS
|
US20230203445A1
(en)
|
2020-05-26 |
2023-06-29 |
Healios K.K. |
Hypoimmunogenic cells
|
EP4159838A1
(en)
|
2020-05-28 |
2023-04-05 |
Orizuru Therapeutics, Inc. |
Mass production method of uniform size cell aggregate
|
EP3922431A1
(en)
|
2020-06-08 |
2021-12-15 |
Erasmus University Medical Center Rotterdam |
Method of manufacturing microdevices for lab-on-chip applications
|
WO2021250058A2
(en)
|
2020-06-12 |
2021-12-16 |
Bayer Aktiengesellschaft |
CRISPR-Cas12a DIRECTED RANDOM MUTAGENESIS AGENTS AND METHODS
|
EP4170020A1
(en)
|
2020-06-17 |
2023-04-26 |
Kyoto University |
Chimeric antigen receptor-expressing immunocompetent cells
|
JP7429294B2
(ja)
|
2020-07-13 |
2024-02-07 |
国立大学法人京都大学 |
骨格筋前駆細胞及びその精製方法、筋原性疾患を治療するための組成物、並びに骨格筋前駆細胞を含む細胞群の製造方法
|
JPWO2022019152A1
(zh)
|
2020-07-20 |
2022-01-27 |
|
|
EP4202041A1
(en)
|
2020-08-18 |
2023-06-28 |
Kyoto University |
Method for maintaining and amplifying human primordial germ cells / human primordial germ cell-like cells
|
CN116391028A
(zh)
|
2020-11-20 |
2023-07-04 |
千纸鹤治疗公司 |
促熟剂
|
KR20230145101A
(ko)
|
2021-02-09 |
2023-10-17 |
오리즈루 세라퓨틱스 가부시키가이샤 |
성숙화제
|
USD969942S1
(en)
*
|
2021-03-03 |
2022-11-15 |
Amber Puchlov |
Exercise device
|
JPWO2022191171A1
(zh)
|
2021-03-09 |
2022-09-15 |
|
|
JPWO2022196714A1
(zh)
|
2021-03-17 |
2022-09-22 |
|
|
CN113106059B
(zh)
*
|
2021-04-07 |
2023-08-15 |
清华大学深圳国际研究生院 |
一种高迁徙间充质干细胞及其制备方法和应用
|
TW202305121A
(zh)
|
2021-04-08 |
2023-02-01 |
日商武田藥品工業股份有限公司 |
T細胞活化方法
|
JPWO2022230919A1
(zh)
|
2021-04-28 |
2022-11-03 |
|
|
AU2022266430A1
(en)
|
2021-04-30 |
2023-12-14 |
Riken |
Cord-like aggregates of retinal pigment epithelial cells, device and production method for producing same, and therapeutic agent comprising said cord-like aggregates
|
WO2022236187A1
(en)
|
2021-05-07 |
2022-11-10 |
Children's Hospital Los Angeles |
Methods for making stem cell-derived enteric neural crest cells and their use in enteric neuropathy treatment
|
WO2022250631A2
(en)
*
|
2021-05-25 |
2022-12-01 |
T.C. Ankara Universitesi Rektorlugu |
Disease model of induced pluripotent stem cell (ipsc)-derived type 2 diabetes mellitus, associated with coronary artery disease
|
WO2022255489A1
(ja)
|
2021-06-04 |
2022-12-08 |
キリンホールディングス株式会社 |
細胞組成物、細胞組成物の製造方法及び細胞組成物を含む医薬組成物
|
CA3222761A1
(en)
|
2021-06-10 |
2022-12-15 |
Ajinomoto Co., Inc. |
Method for producing mesenchymal stem cells
|
IL308896A
(en)
|
2021-06-11 |
2024-01-01 |
Bayer Ag |
Programmable type V RNA endoclase systems
|
EP4101928A1
(en)
|
2021-06-11 |
2022-12-14 |
Bayer AG |
Type v rna programmable endonuclease systems
|
EP4355861A1
(en)
|
2021-06-15 |
2024-04-24 |
Takeda Pharmaceutical Company Limited |
Method for producing natural killer cells from pluripotent stem cells
|
JPWO2023286834A1
(zh)
|
2021-07-15 |
2023-01-19 |
|
|
EP4372079A1
(en)
|
2021-07-15 |
2024-05-22 |
Astellas Pharma Inc. |
Pericyte-like cells expressing vascular endothelial growth factor (vegf) at high level
|
WO2023003025A1
(ja)
|
2021-07-21 |
2023-01-26 |
国立大学法人京都大学 |
網膜組織の製造方法
|
WO2023017848A1
(ja)
|
2021-08-11 |
2023-02-16 |
国立大学法人京都大学 |
腎間質前駆細胞の製造方法並びにエリスロポエチン産生細胞、およびレニン産生細胞の製造方法
|
EP4144841A1
(en)
|
2021-09-07 |
2023-03-08 |
Bayer AG |
Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof
|
WO2023048275A1
(ja)
|
2021-09-27 |
2023-03-30 |
国立大学法人京都大学 |
T細胞の製造方法
|
US20230241118A1
(en)
|
2021-10-20 |
2023-08-03 |
University Of Rochester |
Rejuvenation treatment of age-related white matter loss
|
CA3234404A1
(en)
|
2021-10-20 |
2023-04-27 |
Steven A. Goldman |
Treatment with genetically modified cells, and genetically modified cells per se, with increased competitive advantage and/or decreased competitive disadvantage
|
WO2023069843A1
(en)
|
2021-10-20 |
2023-04-27 |
University Of Rochester |
Humanized chimeras for the prospective assessment of cell addition and replacement therapies
|
IL311786A
(en)
|
2021-10-21 |
2024-05-01 |
Vertex Pharma |
hypoimmune cells
|
IL311636A
(en)
|
2021-11-01 |
2024-05-01 |
Vertex Pharma |
Differentiation of stem cell-derived pancreatic islets
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023118068A1
(en)
|
2021-12-23 |
2023-06-29 |
Bayer Aktiengesellschaft |
Novel small type v rna programmable endonuclease systems
|
WO2023150557A1
(en)
|
2022-02-01 |
2023-08-10 |
University Of Rochester |
Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methods
|
WO2023167986A1
(en)
|
2022-03-02 |
2023-09-07 |
Lineage Cell Therapeutics, Inc. |
Methods and compositions for treating hearing loss
|
WO2023211857A1
(en)
|
2022-04-25 |
2023-11-02 |
Lineage Cell Therapeutics, Inc. |
Methods and compositions for treating vision loss
|
WO2023215455A1
(en)
|
2022-05-05 |
2023-11-09 |
University Of Rochester |
Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease
|
WO2023237587A1
(en)
|
2022-06-10 |
2023-12-14 |
Bayer Aktiengesellschaft |
Novel small type v rna programmable endonuclease systems
|
WO2023247532A1
(en)
|
2022-06-21 |
2023-12-28 |
Institut National de la Santé et de la Recherche Médicale |
A method for producing a bioengineered mammal induced pluripotent stem cell-derived cardiac organoid
|